1. Home
  2. ALBT vs SMTK Comparison

ALBT vs SMTK Comparison

Compare ALBT & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • SMTK
  • Stock Information
  • Founded
  • ALBT 2014
  • SMTK 2009
  • Country
  • ALBT United States
  • SMTK United Kingdom
  • Employees
  • ALBT N/A
  • SMTK N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • SMTK
  • Sector
  • ALBT Health Care
  • SMTK
  • Exchange
  • ALBT Nasdaq
  • SMTK NYSE
  • Market Cap
  • ALBT 5.7M
  • SMTK 6.1M
  • IPO Year
  • ALBT N/A
  • SMTK N/A
  • Fundamental
  • Price
  • ALBT $2.73
  • SMTK $0.93
  • Analyst Decision
  • ALBT
  • SMTK
  • Analyst Count
  • ALBT 0
  • SMTK 0
  • Target Price
  • ALBT N/A
  • SMTK N/A
  • AVG Volume (30 Days)
  • ALBT 87.1K
  • SMTK 150.8K
  • Earning Date
  • ALBT 08-18-2025
  • SMTK 08-11-2025
  • Dividend Yield
  • ALBT N/A
  • SMTK N/A
  • EPS Growth
  • ALBT N/A
  • SMTK N/A
  • EPS
  • ALBT N/A
  • SMTK N/A
  • Revenue
  • ALBT $807,235.00
  • SMTK $105,000.00
  • Revenue This Year
  • ALBT N/A
  • SMTK N/A
  • Revenue Next Year
  • ALBT N/A
  • SMTK N/A
  • P/E Ratio
  • ALBT N/A
  • SMTK N/A
  • Revenue Growth
  • ALBT N/A
  • SMTK 854.54
  • 52 Week Low
  • ALBT $2.11
  • SMTK $0.78
  • 52 Week High
  • ALBT $12.60
  • SMTK $7.80
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 54.02
  • SMTK N/A
  • Support Level
  • ALBT $2.65
  • SMTK N/A
  • Resistance Level
  • ALBT $3.79
  • SMTK N/A
  • Average True Range (ATR)
  • ALBT 0.27
  • SMTK 0.00
  • MACD
  • ALBT 0.05
  • SMTK 0.00
  • Stochastic Oscillator
  • ALBT 65.85
  • SMTK 0.00

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

Share on Social Networks: